article thumbnail

Tesla, Nvidia, Lululemon and more

CFO News Room

Regeneron – Regeneron slipped 5% after the pharmaceutical company said that sales of its Eylea drug were negatively impacted in the final quarter of 2022 by a shift to an off-label competitor. Monolithic Power Systems – Shares of Monolithic Power Systems gained 6.4% Oracle – Oracle advanced 2.6%

article thumbnail

Sri Lanka: Recovery Takes Hold

Global Finance

Fragile fiscal balances, ongoing external debt restructuring and high debt servicing costs. Since then, Rajapaksa’s successor, President Ranil Wickremesinghe has presided over yet another tentative economic recovery. Entrenched corruption and bureaucratic red tape. Excessive reliance on tourism and textiles.

Economics 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FTC Submits Progress Report To The Senate

PYMNTS

The testimony also cited the FTC’s order against Herbalife, which had to restructure its business operations and pay $200 million to consumers it had deceived into believing they could earn substantial money selling diet and nutritional products. This year, the FTC brought a $100 million judgment against LifeLock.

article thumbnail

KPMG: Corporate financial performance rebounds in Q3

Future CFO

Many of these companies may already be experiencing distress or working through restructuring strategies. percent), Technology and Telecommunication (6.9%) and Pharmaceuticals (6.3%). In the three-month period, the sectors with the highest proportion of zombies included Raw Materials (with 14.6% zombies), Biotechnology (12.6

article thumbnail

Return on Equity, Earnings Yield and Market Efficiency: Back to Basics!

Musings on Markets

Carrying this through to the real world, you should not be surprised to see technology and pharmaceutical companies, the two biggest spenders on R&D, report much higher accounting returns than they are actually earning on their investments.

article thumbnail

Musings on Markets: Data Update 5 for 2022: The Bottom Line!

CFO News Room

To the extent that accountants mis-categorize expenses like leases and R&D, returns can be skewed, as can restructuring and one-time charges.

Marketing 130
article thumbnail

Data Update 5 for 2022: The Bottom Line!

Musings on Markets

To the extent that accountants mis-categorize expenses like leases and R&D, returns can be skewed, as can restructuring and one-time charges.